# Lumexa Imaging Holdings, Inc.: filings

LMRI · Nasdaq · CIK 2071288 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lmri.md) · [Financials](/companies/lmri/financials.md) · [Filings](/companies/lmri/filings.md) · [Insiders](/companies/lmri/insiders.md)

## Reports and events: 16 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 17, 3 14, 8-K 10, CORRESP 4, UPLOAD 4, DRS/A 3, DRSLTR 3, 10-Q 2, SCHEDULE 13G 2, 10-K 1, 424B4 1, 8-A12B 1, ARS 1, CERT 1, DEF 14A 1, DEFA14A 1, DRS 1, EFFECT 1, S-1 1, S-1/A 1, S-8 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-13 | 14:54 ET | [10-Q](/filings/0001193125-26-348902.md) | Quarterly report, period 2026-06-30 | 0001193125-26-348902 |
| 2026-08-12 | 16:05 ET | [8-K](/filings/0001193125-26-346813.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-346813 |
| 2026-06-30 | 17:08 ET | [8-K](/filings/0001193125-26-290788.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-290788 |
| 2026-06-12 | 16:05 ET | [8-K](/filings/0001193125-26-269379.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-269379 |
| 2026-05-12 | 16:15 ET | [10-Q](/filings/0001193125-26-219480.md) | Quarterly report, period 2026-03-31 | 0001193125-26-219480 |
| 2026-05-12 | 16:08 ET | [8-K](/filings/0001193125-26-219415.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-219415 |
| 2026-04-28 | 16:36 ET | [DEF 14A](/filings/0001193125-26-187316.md) | Proxy statement, period 2026-06-10 | 0001193125-26-187316 |
| 2026-04-09 | 17:11 ET | [8-K](/filings/0001193125-26-149837.md) | 7.01 Regulation FD disclosure | 0001193125-26-149837 |
| 2026-03-30 | 17:32 ET | [10-K](/filings/0001193125-26-131907.md) | Annual report, period 2025-12-31 | 0001193125-26-131907 |
| 2026-03-26 | 06:09 ET | [8-K](/filings/0001193125-26-124978.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-124978 |
| 2026-03-02 | 06:14 ET | [8-K](/filings/0001193125-26-084047.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-084047 |
| 2026-01-15 | 06:48 ET | [8-K](/filings/0001193125-26-013511.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-013511 |
| 2025-12-18 | 16:01 ET | [8-K](/filings/0001193125-25-324774.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-324774 |
| 2025-12-12 | 16:01 ET | [8-K](/filings/0001193125-25-317521.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-317521 |
| 2025-12-02 | 06:34 ET | [S-1/A](/filings/0001193125-25-304460.md) | Registration statement, amended | 0001193125-25-304460 |
| 2025-11-17 | 16:24 ET | [S-1](/filings/0001193125-25-284663.md) | Registration statement | 0001193125-25-284663 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.